Girish Nadkarni of Avendus Capital told CNBC-TV18, "From a short-term perspective it is safe to buy some of the good quality domestic formulation companies in the pharma side or some of the exporters of generic pharma companies. Also, consumer stocks I know they are trading at highs, but demand will continue to be strong for the consumer non-durable segment and those are safer bets in the current market."
"From a three-year perspective one could buy most stocks, maybe a little cheaper from the current levels, across the board," he added. Also Read: Sun Pharma gets US FDA nod for Riluzole 50mg tablets
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
